BrB-101

N/A

Report date: 2025/08/14 17:46:51

Base Information

Drug NameBrB-101
Drug Alias NameCOL7A1 CRISPR/Cas9-gene therapy (Branca Bunus)anti-COL7A1 gene ribonucleoprotein complex program (Branca Bunus)
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas9
Mechanisms of ActionCOL7A1 gene transference
TargetsCollagen alpha-1(VII) chain
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBranca Bunús Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBranca Bunús Ltd
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A